Sandoz to acquire antifungal agent Mycamine from Astellas
The addition of Mycamine is expected to considerably strengthen Sandoz’s hospital offering, anti-infective portfolio, and a global programme…
Sun Pharma to buy US-based Concert Pharmaceuticals for $576m
20 Jan 23Concert Pharmaceuticals’ deuruxolitinib is an oral inhibitor of Janus kinases JAK1 and JAK2, which is currently in late-stage…
AstraZeneca to buy cardiorenal diseases company CinCor for $1.8bn
10 Jan 23The acquisition will provide AstraZeneca with access to global rights to baxdrostat, CinCor’s novel aldosterone synthase inhibitor drug…
Chiesi Farmaceutici to acquire Amryt Pharma for up to $1.48bn
09 Jan 23Amryt Pharma is a commercial-stage biopharmaceutical firm that acquires, develops and commercialises treatments to help improve the lives…
Moderna to acquire Japan’s Oriciro Genomics for $85m
05 Jan 23The acquisition is expected to support Moderna’s suite of platform technologies, and OriCiro’s synthetic biology and enzyme technologies…
Blacksmith, Forge to merge for developing metalloenzymes-targeting drugs
03 Jan 23Under the deal, both firms will use their combined chemistry platforms to create a biopharma that will develop…
Kite to acquire CAR T-cell therapy company Tmunity Therapeutics
21 Dec 22The acquisition will complement Kite’s existing in-house research capabilities and provide Kite with rapid manufacturing processes, Armored CAR…
Fujifilm to acquire Inspirata’s digital pathology business
20 Dec 22The acquisition of Inspirata’s digital pathology technology and its team will help Fujifilm to expand its Synapse Enterprise…
Takeda to buy NDI-034858 from Nimbus Therapeutics in deal worth up to $6bn
14 Dec 22To be renamed TAK-279 after the completion of the deal, NDI-034858 is being studied for the treatment of…
Amgen to acquire Horizon Therapeutics in $27.8bn deal
13 Dec 22Horizon Therapeutics is a biotechnology company focused on discovering, developing, and marketing medicines that for rare, autoimmune, and…